Design of the ABCA1 agonist CS6253 Phase 1 SAD and MAD study in male and female, APOE4 and non-APOE4 carriers to assess safety, PK and biomarker efficacy

Cogpep (CS6253) - Artery Therap, University of California Berkeley

J. Johansson1; H. Yassine2; D. Michaelson3; H. Zetterberg4; J. Cummings5; B. Winblad6

Oct 5, 2022